EZH2 and non-small cell lung carcinoma: DANCR is significantly overexpressed in NSCLC and enhances the binding of EZH2 to p21, increasing H3K27me3 modification at the p21 promoter region, which inhibits p21 expression and promotes NSCLC cell proliferation36.